Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniela Stadler

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|December 16, 2016
Analyses of HBV cccDNA Quantification and ModificationYuchen Xia, Daniela Stadler, Chunkyu Ko, et al.
Medecine Sciences : M/S|September 2, 2014
[Specific degradation of nuclear hepatitis B virus covalently closed circular DNA]Julie Lucifora, Yuchen Xia, Florian Reisinger, et al.
Acta Crystallographica. Section D, Biological Crystallography|March 23, 2013
Structure of LdtMt2, an L,D-transpeptidase from Mycobacterium tuberculosisDominic Böth, Eva Maria Steiner, Daniela Stadler, et al.
Computational and Structural Biotechnology Journal|February 7, 2022
Montelukast is a dual-purpose inhibitor of SARS-CoV-2 infection and virus-induced IL-6 expression identified by structure-based drug repurposingMax Luedemann, Daniela Stadler, Cho-Chin Cheng, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|May 26, 2024
Challenges in the analysis of pharmaceutical lentiviral vector products by orthogonal and complementary physical (nano)particle characterization techniquesDaniela Stadler, Constanze Helbig, Klaus Wuchner, et al.
Journal of Pharmaceutical Sciences|December 17, 2021
Particles in Biopharmaceutical Formulations, Part 2: An Update on Analytical Techniques and Applications for Therapeutic Proteins, Viruses, Vaccines and CellsAlexandra Roesch, Sarah Zölls, Daniela Stadler, et al.
The Journal of Infectious Diseases|March 30, 2019
Comparative Analysis of the Antiviral Effects Mediated by Type I and III Interferons in Hepatitis B Virus-Infected HepatocytesJan-Hendrik Bockmann, Daniela Stadler, Yuchen Xia, et al.
Mbio|May 8, 2023
Apobec3A Deamination Functions Are Involved in Antagonizing Efficient Human Adenovirus Replication and Gene ExpressionLilian Göttig, Christina Weiß, Miona Stubbe, et al.
Antiviral Research|November 16, 2018
PASylated interferon α efficiently suppresses hepatitis B virus and induces anti-HBs seroconversion in HBV-transgenic miceYuchen Xia, Martin Schlapschy, Volker Morath, et al.
Journal of Extracellular Vesicles|December 28, 2020
Efficient and reproducible depletion of hepatitis B virus from plasma derived extracellular vesiclesStephanie Jung, Karolin Fiona Kirsten Jacobs, Mikhail Shein, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Methods in Molecular Biology (Clifton, N.J.)|December 16, 2016
Analyses of HBV cccDNA Quantification and ModificationYuchen Xia, Daniela Stadler, Chunkyu Ko, et al.
Medecine Sciences : M/S|September 2, 2014
[Specific degradation of nuclear hepatitis B virus covalently closed circular DNA]Julie Lucifora, Yuchen Xia, Florian Reisinger, et al.
Acta Crystallographica. Section D, Biological Crystallography|March 23, 2013
Structure of LdtMt2, an L,D-transpeptidase from Mycobacterium tuberculosisDominic Böth, Eva Maria Steiner, Daniela Stadler, et al.
Computational and Structural Biotechnology Journal|February 7, 2022
Montelukast is a dual-purpose inhibitor of SARS-CoV-2 infection and virus-induced IL-6 expression identified by structure-based drug repurposingMax Luedemann, Daniela Stadler, Cho-Chin Cheng, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|May 26, 2024
Challenges in the analysis of pharmaceutical lentiviral vector products by orthogonal and complementary physical (nano)particle characterization techniquesDaniela Stadler, Constanze Helbig, Klaus Wuchner, et al.
Journal of Pharmaceutical Sciences|December 17, 2021
Particles in Biopharmaceutical Formulations, Part 2: An Update on Analytical Techniques and Applications for Therapeutic Proteins, Viruses, Vaccines and CellsAlexandra Roesch, Sarah Zölls, Daniela Stadler, et al.
The Journal of Infectious Diseases|March 30, 2019
Comparative Analysis of the Antiviral Effects Mediated by Type I and III Interferons in Hepatitis B Virus-Infected HepatocytesJan-Hendrik Bockmann, Daniela Stadler, Yuchen Xia, et al.
Mbio|May 8, 2023
Apobec3A Deamination Functions Are Involved in Antagonizing Efficient Human Adenovirus Replication and Gene ExpressionLilian Göttig, Christina Weiß, Miona Stubbe, et al.
Antiviral Research|November 16, 2018
PASylated interferon α efficiently suppresses hepatitis B virus and induces anti-HBs seroconversion in HBV-transgenic miceYuchen Xia, Martin Schlapschy, Volker Morath, et al.
Journal of Extracellular Vesicles|December 28, 2020
Efficient and reproducible depletion of hepatitis B virus from plasma derived extracellular vesiclesStephanie Jung, Karolin Fiona Kirsten Jacobs, Mikhail Shein, et al.
Pageof 2